IQVIA is an American healthcare and clinical research company focused on health information technology, analytics, and contract research services. It is headquartered in Durham, North Carolina and traces its founding to 1982. The company is publicly traded on the NYSE under IQV.
The global AI in clinical trials market is expected to grow from $2.09 billion currently to $18.62 billion by 2040, driven by enhanced patient recruitment, optimized trial designs, and automation that reduces time and costs in drug development.
The clinical trials industry is expected to grow from $61.93 billion in 2025 to $99.25 billion by 2033 at a 6.07% CAGR, driven by demand for innovative therapies and chronic disease prevalence. Clinical trials management systems are projected to reach $9.0 billion by 2035.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07603193 |
Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream |
ENROLLING_BY_INVITATION | |
| NCT02846753 |
Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts |
UNKNOWN | NA |
